Connection Between Epigenome, Selective Mutability, Evolution, and Human Disease
Li, Harris et al., PLoS Genetics
Researchers at the Baylor College of Medicine and elsewhere propose a "connection between the epigenome, selective mutability, evolution, and human disease" based on the findings of their study on associations of structural mutability with germline DNA methylation and with non-allelic homologous recombination mediated by low-copy repeats. "Combined evidence from four human sperm methylome maps, human genome evolution, structural polymorphisms in the human population, and previous genomic and disease studies consistently points to a strong association of germline hypomethylation and genomic instability," the Baylor-led team writes.
GAO Stands By Its 2010 Report on DTC Genomics Firms; Lead Investigator Assigned to New Position
March 16, 2011
The Government Accountability Office squelched a rumor that has been circulating about the firing of an agency investigator due to errors in a report on for-profit colleges. Additionally, the agency said it has not "identified any problems" with a report on the DTC genomics industry that was led by the same investigator.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register quickly here.
New to GenomeWeb? Register quickly here.
Related Stories
- In Wake of 'Flawed' GAO Report, Consumer Genomics Firms Call for Regulatory Plan for DTC Industry
July 28, 2010 / Pharmacogenomics Reporter - As Congress Investigates DTC Genomics Market, Firms Vow Cooperation
May 26, 2010 / Pharmacogenomics Reporter - American Bar Association Passes Resolution on DTC Marketing of Genetic Tests
August 24, 2011 / Pharmacogenomics Reporter - DTC Genomics Firms Say They Want to Comply with FDA Regs but Maintain Direct Access
March 16, 2011 / Pharmacogenomics Reporter - ASU Biodesign Scientists Hope to Apply Direct-to-Consumer Model to Proteomics Testing
February 4, 2011 / ProteoMonitor